CRGO(CRGO)
CRGO
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $30M | $34M | $39M | $73M |
| Low | $30M | $33M | $39M | $72M |
| High | $31M | $34M | $39M | $73M |
| EBITDA Avg | $-8M | $-1M | $5M | $3M |
| Low | $-8M | $-1M | $5M | $3M |
| High | $-7M | $-1M | $5M | $3M |
| EBIT Avg | $-10M | $-4M | $3M | $2M |
| Low | $-10M | $-4M | $3M | $2M |
| High | $-10M | $-3M | $4M | $2M |
| Net Income Avg | $-11M | $-4M | $3M | $1M |
| Low | $-11M | $-4M | $3M | $1M |
| High | $-11M | $-4M | $3M | $1M |
| EPS Avg | $-0.21 | $-0.07 | $0.05 | $0.02 |
| Low | $-0.21 | $-0.08 | $0.05 | $0.02 |
| High | $-0.21 | $-0.07 | $0.05 | $0.02 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $8M | $8M | $8M | $8M | $8M | $8M |
| Low | $8M | $8M | $8M | $8M | $8M | $8M |
| High | $8M | $8M | $8M | $8M | $8M | $9M |
| EBITDA Avg | $-1M | $-1M | $-239,795 | $-273,009 | $-823,027 | $-852,984 |
| Low | $-1M | $-1M | $-247,316 | $-280,530 | $-834,309 | $-864,266 |
| High | $-1M | $-1M | $-232,273 | $-265,487 | $-811,744 | $-841,701 |
| EBIT Avg | $-2M | $-2M | $-971,467 | $-971,467 | $-1M | $-1M |
| Low | $-2M | $-2M | $-978,988 | $-978,988 | $-2M | $-2M |
| High | $-2M | $-2M | $-963,945 | $-963,945 | $-1M | $-1M |
| Net Income Avg | $-2M | $-2M | $-1M | $-1M | $-2M | $-2M |
| Low | $-2M | $-2M | $-1M | $-1M | $-2M | $-2M |
| High | $-2M | $-2M | $-1M | $-1M | $-2M | $-2M |
| EPS Avg | $-0.04 | $-0.04 | $-0.02 | $-0.02 | $-0.03 | $-0.03 |
| Low | $-0.05 | $-0.04 | $-0.02 | $-0.02 | $-0.03 | $-0.03 |
| High | $-0.04 | $-0.04 | $-0.02 | $-0.02 | $-0.03 | $-0.03 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |